Synlait PBT swung to a NZ$94.9m loss with net debt at 28x EBITDA

What changed

Revenue from continuing operations fell 15.2% to NZ$652.9m from NZ$769.8m. PBT swung from a NZ$6.1m profit to a NZ$94.9m loss, and bottom-line NPAT moved from NZ$4.8m to a NZ$96.2m loss. Continuing-operations NPAT was a NZ$70.0m loss; a further NZ$26.2m loss from discontinued operations took the result the rest of the way down, so the PBT/NPAT divergence is explained by that disclosed discontinued-operation loss plus a NZ$24.9m tax benefit at continuing-ops level rather than anything unexplained. EBITDA was disclosed at NZ$19.9m with no prior comparable provided.

Segment mix was broadly unchanged (Synlait ~82% of revenue, Dairyworks ~18%), but both segments swung from profit to loss — Synlait from NZ$1.4m to a NZ$70.0m loss, Dairyworks from NZ$3.4m to a NZ$26.2m loss — so this is broad margin pressure, not a mix problem.

Operating cash outflow narrowed to NZ$98.1m from NZ$124.7m, helped by a NZ$151.5m (32.4%) inventory drawdown. Capex was cut to NZ$16.7m (from NZ$27.5m), but free cash flow pre-lease was still NZ$114.8m negative. Cash rose to NZ$30.5m; gross borrowings rose to NZ$589.8m (from NZ$529.3m), taking net debt to about NZ$559.3m. Equity fell to NZ$698.9m from NZ$814.8m.

What matters

• Leverage is the dominant issue. Net debt of NZ$559.3m against NZ$19.9m half-year EBITDA implies roughly 28.1x on a current-period basis. Management has flagged a plan to deleverage and explicitly referenced "elevated levels of debt" and a review that "is expected to take several months, and there is no certainty that any transaction will result." Everything else — dividend capacity, strategic optionality, covenant headroom — sits downstream of that.
• Earnings quality deteriorated across the board, not at a single line. Both segments turned loss-making with stable revenue shares, which points to pricing, cost, or operating-leverage problems rather than a one-off. The NZ$24.9m tax benefit and the NZ$26.2m discontinued-operations loss distort NPAT; PBT (−NZ$94.9m vs +NZ$6.1m) is the cleaner operating read and it is materially worse.
• Working capital, not trading, funded the operating cash improvement. The NZ$151.5m inventory reduction is the principal reason the operating outflow narrowed; on an EBITDA base of NZ$19.9m the OCF/EBITDA ratio is −493%, which is not a normalised cash-generation profile.

Expectations

No quantitative revenue, earnings, or leverage targets were disclosed. Annualising HY24 revenue gives NZ$1.3b, roughly 1.1% below FY23's NZ$1.3b — so the current run-rate is slightly softer than the FY23 anchor rather than signalling a pickup. The FY23 shape showed HY23 at 58.3% of full-year revenue and HY23 NPAT already above the full-year number (FY23 NPAT was a NZ$4.3m loss), implying a weaker second half historically; on that pattern, HY24's NZ$96.2m loss does not bias 2H24 toward recovery absent a specific catalyst, and none is quantified in the release. The stated deleveraging intent is directional only — no timing, no proceeds range, no target gearing.

Quality of result

Low durability. The operating cash improvement is inventory-driven, not margin-driven, and inventory unwinds do not repeat indefinitely. EBITDA is disclosed without a full bridge to operating profit, so the NZ$19.9m figure sits with limited reconciliation transparency. Capex was meaningfully lower (2.6% of revenue vs 3.6%), which helps reported free cash flow but is a balance-sheet assist rather than a trading gain. Receivable days improved modestly to 30.5 (from 33.1), which is neutral-to-mildly-positive. The tax benefit and the discontinued-operations loss are both below-the-line, so the underlying read is the −NZ$94.9m PBT — and that is what should frame any forward view.

Unresolved

• What business the NZ$26.2m discontinued-operations loss relates to, and whether the associated disposal proceeds materially contribute to the flagged deleveraging.
• Covenant position and headroom on the expanded NZ$589.8m borrowings base, which the extraction does not quantify.
• Whether the NZ$19.9m EBITDA includes non-recurring items; no formal non-GAAP reconciliation was extracted.
• The driver of the segment margin collapse — pricing, input costs, volume, or customer-specific issues — is not decomposed.
• Whether the inventory drawdown is a structural rebase or a one-time normalisation, which determines how much of the cash improvement is repeatable.

This briefing cannot assess covenant status, the likelihood or economics of any deleveraging transaction, or the underlying unit-economics drivers behind the segment-level swing to losses.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.